Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030
Roots Analysis has announced the addition of "Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030" report to its list of offerings.
By: Roots Analysis
The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to cater to the evolving needs. It is also worth highlighting that stakeholders engaged in this domain are actively undertaking initiatives to develop interventions for SARS-CoV-2 virus.
To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this link
Key Market Insights
Presently, more than 80 players claim to offer services for antibody discovery
Over 90% of the aforementioned players provide services for hit generation, followed by those offering services for antibody humanization (58%). It is worth mentioning that five service providers claim to have the required expertise to serve as one-stop-shops for all the antibody discovery steps.
More than 120 companies offer antibody discovery platforms
It is worth highlighting that close to 180 technologies focused on antibody discovery are presently available in the market. Further, nearly 50% platforms use library-based methods to discover antibodies. Amongst these, phage display is currently the most widely used technique. This is followed by single cell-based methods (20%).
Partnership activity within this domain has grown at a CAGR of 18%, between 2015 and 2020
In the last five years, more than 400 agreements were inked related to antibody discovery, with the maximum activity being reported in 2018. Majority of partnership deals signed within this domain were licensing agreements (25%), product development and commercialization agreements (24%), and R&D agreements (18%).
Nearly USD 7 billion has been invested in the antibody discovery domain, during 2016-2020
For additional details, please visit
or email firstname.lastname@example.org
You may also be interested in the following titles:
1. Antibody Contract Manufacturing Market, 2020 – 2030 (https://www.rootsanalysis.com/
2. Antibody Drug Conjugates Market (5th Edition), 2019-2030
3. Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030
+1 (415) 800 3415